Literature DB >> 30251670

Determinative factors in inhibition of aquaporin by different pharmaceuticals: Atomic scale overview by molecular dynamics simulation.

Vahid Fadaei Naeini1, Masumeh Foroutan2, Mina Maddah2, Yves Rémond3, Majid Baniassadi4.   

Abstract

The inhibition of water permeation through aquaporins by ligands of pharmaceutical compounds is considered as a method to control the cell lifetime. The inhibition of aquaporin 1 (AQP1) by bacopaside-I and torsemide, was explored and its atomistic nature was elucidated by molecular docking and molecular dynamics (MD) simulation collectively along with Poisson-Boltzmann surface area (PBSA) method. Docking results revealed that torsemide has a lower level of docking energy in comparison with bacopaside-I at the cytoplasmic side. Furthermore, the effect of steric constraints on water permeation was accentuated. Bacopaside-I inhibits the channel properly due to the strong interaction with the channel and larger spatial volume, whereas torsemide blocks the cytoplasmic side of the channel imperfectly. The most probable active sites of AQP1 for the formation of hydrogen bonds between the inhibitor and the channel were identified by numerical analysis of the bonds. Eventually, free energy assessments indicate that binding of both inhibitors is favorable in complex with AQP1, and van der Waals interaction has an important contribution in stabilizing the complexes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aquaporin; Bacopaside-I; Binding free energy; Inhibition; Molecular docking; Molecular dynamics simulation; Torsemide

Mesh:

Substances:

Year:  2018        PMID: 30251670     DOI: 10.1016/j.bbagen.2018.09.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  1 in total

1.  Decisive structural elements in water and ion permeation through mechanosensitive channels of large conductance: insights from molecular dynamics simulation.

Authors:  Vahid Fadaei Naeini; Majid Baniassadi; Masumeh Foroutan; Yves Rémond; Daniel George
Journal:  RSC Adv       Date:  2022-06-16       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.